Li C - Search Results

1

Dystrophin immunity in Duchenne's muscular dystrophy.

Mendell JR, Campbell K, Rodino-Klapac L, Sahenk Z, Shilling C, Lewis S, Bowles D, Gray S, Li C, Galloway G, Malik V, Coley B, Clark KR, Li J, Xiao X, Samulski J, McPhee SW, Samulski RJ, Walker CM. Mendell JR, et al. Among authors: li c, li j. N Engl J Med. 2010 Oct 7;363(15):1429-37. doi: 10.1056/NEJMoa1000228. N Engl J Med. 2010. PMID: 20925545 Free PMC article. Clinical Trial.

2

Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors.

Chao H, Liu Y, Rabinowitz J, Li C, Samulski RJ, Walsh CE. Chao H, et al. Among authors: li c. Mol Ther. 2000 Dec;2(6):619-23. doi: 10.1006/mthe.2000.0219. Mol Ther. 2000. PMID: 11124063 Free article.

3

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.

Rabinowitz JE, Rolling F, Li C, Conrath H, Xiao W, Xiao X, Samulski RJ. Rabinowitz JE, et al. Among authors: li c. J Virol. 2002 Jan;76(2):791-801. doi: 10.1128/jvi.76.2.791-801.2002. J Virol. 2002. PMID: 11752169 Free PMC article.

4

Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector production.

Li C, Samulski RJ. Li C, et al. Virology. 2005 Apr 25;335(1):10-21. doi: 10.1016/j.virol.2005.02.008. Virology. 2005. PMID: 15823602 Free article.

5

Adeno-associated virus vectors: potential applications for cancer gene therapy.

Li C, Bowles DE, van Dyke T, Samulski RJ. Li C, et al. Cancer Gene Ther. 2005 Dec;12(12):913-25. doi: 10.1038/sj.cgt.7700876. Cancer Gene Ther. 2005. PMID: 15962012 Free PMC article. Review.

6

Endostatin therapy reveals a U-shaped curve for antitumor activity.

Tjin Tham Sjin RM, Naspinski J, Birsner AE, Li C, Chan R, Lo KM, Gillies S, Zurakowski D, Folkman J, Samulski J, Javaherian K. Tjin Tham Sjin RM, et al. Among authors: li c. Cancer Gene Ther. 2006 Jun;13(6):619-27. doi: 10.1038/sj.cgt.7700938. Cancer Gene Ther. 2006. PMID: 16456550

7

Immune responses to AAV in a phase I study for Canavan disease.

McPhee SW, Janson CG, Li C, Samulski RJ, Camp AS, Francis J, Shera D, Lioutermann L, Feely M, Freese A, Leone P. McPhee SW, et al. Among authors: li c. J Gene Med. 2006 May;8(5):577-88. doi: 10.1002/jgm.885. J Gene Med. 2006. PMID: 16532510 Clinical Trial.

8

Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo.

Li C, Hirsch M, Asokan A, Zeithaml B, Ma H, Kafri T, Samulski RJ. Li C, et al. J Virol. 2007 Jul;81(14):7540-7. doi: 10.1128/JVI.00529-07. Epub 2007 May 2. J Virol. 2007. PMID: 17475652 Free PMC article.

9

Adeno-associated virus of a single-polarity DNA genome is capable of transduction in vivo.

Zhou X, Zeng X, Fan Z, Li C, McCown T, Samulski RJ, Xiao X. Zhou X, et al. Among authors: li c. Mol Ther. 2008 Mar;16(3):494-9. doi: 10.1038/sj.mt.6300397. Epub 2008 Jan 8. Mol Ther. 2008. PMID: 18180769 Free article.

10

Bioluminescent virion shells: new tools for quantitation of AAV vector dynamics in cells and live animals.

Asokan A, Johnson JS, Li C, Samulski RJ. Asokan A, et al. Among authors: li c. Gene Ther. 2008 Dec;15(24):1618-22. doi: 10.1038/gt.2008.127. Epub 2008 Jul 31. Gene Ther. 2008. PMID: 18668144 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82,108 results

Search Page